Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Hypertension. 2020 Jan 27;75(3):660–667. doi: 10.1161/HYPERTENSIONAHA.119.14309

Table 1.

Baseline characteristics, overall and by baseline orthostatic hypotension status

Overall (N = 8792) No Baseline OH (N = 8156) Baseline OH (N = 636)
Age, years 67.6 (9.3) 67.5 (9.3) 69.4 (9.3)
Age ≥75 years, % 26.9 26.3 34.6
Female, % 35.0 34.6 40.9
Black, % 31.3 31.9 23.7
Mean SBP, mmHg 139.6 (15.6) 139.1 (15.5) 145.2 (16.5)
Mean DBP, mmHg 78.2 (11.9) 78.1 (11.9) 79.9 (12.3)
eGFR, mL/min/1.73 m2 72.2 (20.4) 72.6 (20.2) 66.3 (21.3)
Body mass index, kg/m2 29.9 (5.8) 30.0 (5.8) 29.2 (5.6)
HDL cholesterol, mg/dL 52.8 (14.4) 52.7 (14.4) 53.4 (14.2)
Total cholesterol, mg/dL 187.0 (42.5) 187.1 (42.4) 185.3 (43.5)
Statin use, % 43.3 43.0 48.0
Chronic kidney disease, % 27.4 26.4 40.1
Subclinical or clinical CVD, % 19.9 19.7 22.3
Smoking status, %
 Never 43.8 44.0 42.0
 Former 42.8 42.6 45.6
 Current 13.4 13.5 12.4
Number of hypertensive agents prescribed at baseline, %
 0 9.1 9.1 8.2
 1 34.8 34.9 33.0
 2 34.0 34.1 33.6
 3 17.9 17.6 21.1
 ≥4 4.2 4.2 4.1
Self-reported dizziness with standing, %* 4.3 4.2 5.5

Abbreviations: CVD, cardiovascular disease; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; OH, orthostatic hypotension; SBP, systolic blood pressure

Note: Total N for those reporting dizziness was 8791/8155/636.